2020
DOI: 10.1016/j.avsg.2020.02.013
|View full text |Cite
|
Sign up to set email alerts
|

Outcomes of Onyx® Embolization of Type II Endoleaks After Endovascular Repair of Abdominal Aortic Aneurysms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
25
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 14 publications
(29 citation statements)
references
References 16 publications
1
25
0
Order By: Relevance
“…However, the definition of clinical success was not uniform and included the lack of evidence of a residual endoleak and/or the detection of a stable or regressive aneurysm diameter on follow-up CT imaging [24]. Similar clinical success rates for T2EL were also found in later studies with EVOH being used alone or in combination with coils [17,26,27,43]. On a retrospective basis, technically incomplete embolization of T2ELs with EVOH does not necessarily rule out clinical success [26].…”
Section: Technical and Clinical Results Achieved With Evohmentioning
confidence: 98%
See 2 more Smart Citations
“…However, the definition of clinical success was not uniform and included the lack of evidence of a residual endoleak and/or the detection of a stable or regressive aneurysm diameter on follow-up CT imaging [24]. Similar clinical success rates for T2EL were also found in later studies with EVOH being used alone or in combination with coils [17,26,27,43]. On a retrospective basis, technically incomplete embolization of T2ELs with EVOH does not necessarily rule out clinical success [26].…”
Section: Technical and Clinical Results Achieved With Evohmentioning
confidence: 98%
“…The goal of T2EL treatment is to stop flow within the endoleak cavity and to relieve pressure in the aneurysm sac. For technical success of the intervention, the embolization endpoint includes filling of the nidus with an embolic agent with all involved branches ideally being blocked [17,26,27]. Clinical success has been achieved when the aneurysm remains stable or shrinks in postinterventional follow-up.…”
Section: Intervention Objectivementioning
confidence: 99%
See 1 more Smart Citation
“…In the past, non-adhesive liquid embolic agents have been widely used in intracranial district for cerebral aneurysms [ 61 ], but rarely in abdominal district for VAAs [ 62 ]. Nowadays, ethylene vinyl alcohol copolymer (EVOH) agents, well-known as Onyx (Medtronic, Dublin, Ireland), Squid (Emboflu, Gland, Switzerland) and Phil (Precipitating Hydrophobic Injectable Liquid, MicroVention, Terumo, Austin, USA), are routinely used in many abdominal diseases [ 63 , 64 , 65 , 66 , 67 ] and also in splenic [ 68 ], hepatic [ 69 ], mesenteric [ 70 ] and renal aneurysms [ 71 ]. These liquid embolic agents are EVOH copolymers mixed with micronized tantalum powder and dissolved in dimethyl sulfoxide (DMSO).…”
Section: Embolization: Techniques and Materialsmentioning
confidence: 99%
“…Endoleaks remain one of the most frequent indications for secondary interventions after endovascular aneurysm repair (EVAR) and fenestrated-branched EVAR. [1][2][3] The reported incidence of sac enlargement after EVAR ranges from 0.2% to 41%, mostly due to an identifiable endoleak. 4 Computed tomography angiography (CTA) with delayed phase is typically the imaging modality of choice, but magnetic resonance angiography and contrast-enhanced duplex ultrasound (CEUS) have high sensitivity to detect small endoleaks.…”
mentioning
confidence: 99%